Brief: Labcorp Launches First-Of-Its-Kind Immunoassay To Accelerate Path To Diagnosis Of Alzheimer's Disease
02/04/2025 13:17
April 2 (Reuters) - Labcorp Holdings Inc LH.N: LABCORP LAUNCHES FIRST-OF-ITS-KIND IMMUNOASSAY TO ACCELERATE PATH TO DIAGNOSIS OF ALZHEIMER'S DISEASE Source text: ID:nPnbbJGzTa Further company coverage: LH.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Labcorp Declares Quarterly Dividend
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
Live Markets: Split US congress after 2026 midterms could boost healthcare stocks, Mizuho says
Deals of the day-Mergers and acquisitions